Utilizing nanoparticle delivery systems can address these challenges by enhancing drug solubility, improving stability, and ensuring targeted delivery to cancer cells, thereby enhancing the therapeutic efficacy and safety profile of Akt inhibitors [101,102,103]. Here, AKT1 is linked to cancer.